tiprankstipranks
BioMarin Pharmaceutical (BMRN)
NASDAQ:BMRN
US Market
BMRN
BioMarin Pharmaceutical
RESEARCH TOOLSreports
Want to see BMRN full AI Analyst Report?

BioMarin Pharmaceutical (BMRN) Income Statement

2,406 Followers

BioMarin Pharmaceutical Income Statement

Last quarter (Q1 2026), BioMarin Pharmaceutical's total revenue was $766.21M, an increase of 2.83% from the same quarter last year. In Q1, BioMarin Pharmaceutical's net income was $105.53M. See BioMarin Pharmaceutical’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 3.22B$ 2.85B$ 2.42B$ 2.10B$ 1.85B
Gross Profit
$ 2.48B$ 2.27B$ 1.89B$ 1.59B$ 1.38B
Operating Expenses
$ 1.95B$ 1.79B$ 1.70B$ 1.43B$ 1.46B
Depreciation and Amortization
$ 79.56M$ 96.43M$ 104.39M$ 101.97M$ 108.04M
EBITDA
$ 572.94M$ 650.53M$ 306.77M$ 265.36M$ 47.43M
Operating Income
$ 533.48M$ 484.21M$ 185.77M$ 160.97M$ -82.34M
Other Income/Expenses
$ -51.00M$ 57.55M$ 2.79M$ -11.40M$ 6.99M
Pretax Income
$ 482.48M$ 541.76M$ 188.56M$ 149.58M$ -75.35M
Net Income
$ 348.90M$ 426.86M$ 167.65M$ 141.56M$ -64.08M
Per Share Metrics
Basic EPS
$ 1.82$ 2.25$ 0.89$ 0.76$ -0.35
Diluted EPS
$ 1.80$ 2.21$ 0.88$ 0.75$ -0.35
Weighted Average Shares Outstanding
 191.79M 190.03M 187.83M 185.27M 182.85M
Weighted Average Shares Outstanding (Diluted)
 197.39M 196.71M 191.59M 188.96M 182.85M
Currency in USD

BioMarin Pharmaceutical Earnings and Revenue History